BP: FY25 Deep Dive
FY25 revenue $189.3B (+0.1%) — net income just $55M (vs $381M FY24, $15.24B FY23). Diluted EPS $0.02. The turnaround year: adjusted FCF +55% on price-adjusted basis; net debt reduced; $2.8B of $4-5B structural cost reduction target delivered. ROACE ~14%. Castrol 65% sale agreed. Bumerangue Brazil discovery: ~8B barrels in place. UBS upgraded N→Buy April 15; HSBC upgraded Reduce→Hold; Wells Fargo $39→$54; Scotiabank $41→$58.
Key Takeaways
BP closed fiscal 2025 (calendar year ended December 31, 2025) at $189.3 billion of revenue, essentially flat YoY (+0.1% from $189.2B FY24). The structural read: this was the turnaround year following multi-year strategy reset under CEO Murray Auchincloss. Net income was just $55 million (vs $381M FY24, $15.24B FY23) — accounting noise from Castrol sale + write-downs + cost program. Adjusted free cash flow grew ~55% YoY on a price-adjusted basis; net debt reduced; $2.8B of the $4-5B structural cost reduction target delivered. ROACE (return on average capital employed) ~14%. Q3 FY25 was strong: upstream production +3% sequentially with plant reliability ~97%; underlying pretax earnings $5.3B; underlying net income $2.2B; operating cash flow $7.8B. Strategic moves in 2025: Castrol 65% sale agreed (post-strategic review); Bumerangue Brazil oil discovery (in-situ analysis materially complete, initial estimate ~8 billion barrels of liquids in place — the largest BP discovery in years); 12 exploration discoveries (Gulf of America, Namibia, Brazil); 7 major upstream projects started up; divestment proceeds upgraded to ~$5B for FY25. Operational: refinery availability >96%; reserves replacement ratio 90% (vs ~50% prior 2-year average). BP also stopped Rotterdam biofuels refinery; sanctioned Tiber in Gulf of America. FY25 capex ~$13.3B; FCF $11.30B (-12% YoY in USD-reported, +55% on adjusted price-normalized basis). Capital allocation: $5.07B in dividends + $4.50B in buybacks. Total debt $84.3B (+$13B). Sell-side coverage in window: UBS upgraded Neutral → Buy on April 15 (no PT disclosed); HSBC upgraded Reduce → Hold on March 20 ($35.10 → $45.30, +$10.20); Wells Fargo $39 → $54 (+$15) on April 9; Scotiabank $41 → $58 on April 22 (+$17, the largest raise). Consensus PT $51.08, range $45.30-$58. 5 analysts: 2 Buy / 3 Hold.
Main business structure
BP operates 3 main segments + corporate:
| Segment | Approx FY25 Revenue / Cash Flow Share | Strategic Focus |
|---|---|---|
| Upstream (E&P + Gas) | ~30% of cash flow | Conventional oil + gas + LNG production |
| Customer & Products (Downstream) | ~30% | Refining + marketing + lubricants (Castrol post-65% sale) |
| Trading & Shipping | ~15% | Distinctive competitive advantage; ~4% uplift to BP returns over 6 years |
| Renewables / Power / Other | ~5% | Lightsource bp + electrification (right-sized) |
Upstream (~30% of cash flow)
- Q3 FY25 production +3% QoQ; plant reliability ~97%
- 7 major projects started up FY25; 5 ahead of schedule
- Reserves replacement ratio 90% (vs ~50% 2-year average) — major improvement
- 12 exploration discoveries FY25: Gulf of America, Namibia, Brazil
- Bumerangue Brazil discovery: ~8B barrels in place; appraisal program planned end-of-year
- Tiber sanctioned in Gulf of America FY25
- Permian + Eagle Ford + Haynesville US shale: BPX productivity improvement (+30% completions, +15% drilling)
Customer & Products / Downstream (~30%)
- $1.6B structural cost reductions delivered to date in Downstream
- Customer business delivered highest underlying earnings since 2019
- Refining capturing better margin environment
- Castrol 65% sale agreed — agreement to sell 65% shareholding (lubricants)
Trading & Shipping (~15%)
- Distinctive competitive advantage
- ~4% uplift to BP's returns over past 6 years (average)
- Q3 strong contribution
Other Strategic Moves FY25
- Stopped Rotterdam biofuels refinery
- Divested Culzean field (North Sea)
- Divestment proceeds upgraded to ~$5B for FY25
- Operational emissions in 2025: 37% less than 2019
Cost Program
- Structural cost reduction target: $4-5B by 2027
- $2.8B delivered FY25 (60-70% of target)
- 1,000+ executive-level role cuts announced 2024 (still flowing through)
Safety + Operational
- 4 colleagues lost lives in US retail (roadside assistance) — permanently stopped roadside assistance next to active traffic lanes
- Operational emissions improved
- Methane intensity improved
Geographic mix. Upstream production: GoM ~25%, North Sea ~10%, Africa ~10%, Asia/MENA ~25%, US shale ~30%.
Customer concentration. Wholesale + retail + commercial customers globally. ~21,000 service stations.
Scale anchors. ~85,000 employees globally. London HQ. ~2.3 MMBOE/d production. Operations in 60+ countries.
Key core metrics (3-year trend)
1. Revenue + the cycle baseline
| FY23 | FY24 | FY25 | |
|---|---|---|---|
| Revenue ($B) | 210.13 | 189.19 | 189.34 |
| YoY | — | -10% | +0.1% |
| Net income ($B) | 15.24 | 0.38 | 0.06 |
The FY25 net income is essentially zero on accounting noise — adjusted earnings + cash flow are the relevant operating metrics.
2. Adjusted FCF (price-adjusted)
- Adjusted FCF grew ~55% YoY on price-adjusted basis FY25
- Reflects cost program delivery + asset optimization
3. Capital allocation
| FY23 | FY24 | FY25 | |
|---|---|---|---|
| OCF ($B) | 32.0 | 27.3 | 24.6 |
| Capex ($B) | 14.29 | 15.30 | 13.25 |
| FCF ($B, USD reported) | 17.75 | 12.00 | 11.30 |
| Dividends ($B) | 4.81 | 5.00 | 5.07 |
| Buybacks ($B) | 7.92 | 7.13 | 4.50 |
| Total debt ($B) | 63.08 | 71.55 | 84.27 |
Buyback pace moderated to $4.5B (vs $7.1B FY24) — reflecting strategic review + capital allocation reset. Dividend held. Total debt expanded materially.
Market evaluation
Sell-side coverage (as of April 27, 2026). 5 analysts cover the stock.
| Rating | Count |
|---|---|
| Buy / Outperform | 2 |
| Hold / Sector Perform | 3 |
| Sell | 0 |
Price targets. Consensus $51.08, range $45.30 (low: HSBC, Hold) to $58 (high: Scotiabank, Sector OP).
Recent analyst activity (Feb-April 2026). 6 covered actions in window — uniformly bullish:
- Scotiabank: $41 → $58 on April 22 — Sector OP maintained, +$17 raise (largest)
- UBS: upgraded Neutral → Buy on April 15 (no PT disclosed) — the structural rating change
- Wells Fargo: $39 → $54 on April 9 — EW maintained, +$15
- HSBC: upgraded Reduce → Hold on March 20, $35.10 → $45.30 — +$10.20
- Piper Sandler: $44 → $47 on March 12; $43 → $44 on Feb 11 — Neutral maintained
The pattern: 2 upgrades + uniformly bullish PT direction — Street's response to the BP turnaround story finally delivering on cost saves + Bumerangue + improved reserves replacement.
Buy-side positioning. BP is increasingly positioned as a turnaround / value play among integrated oil majors. Trades at discount multiple to XOM, CVX, TTE on legacy strategy concerns + slower transition. Short interest below 1.5% of float.
FY25 corporate structure: the turnaround year delivers
FY25 was the year BP's turnaround story finally delivered visible results: $2.8B (60-70%) of $4-5B cost program delivered; reserves replacement ratio 90% (vs 50% prior); 7 major projects started up (5 ahead of schedule); 12 exploration discoveries including ~8B-barrel Bumerangue Brazil; Castrol 65% sale agreed; ROACE ~14%; adjusted FCF +55% price-adjusted. The Street's response was uniformly positive: 2 upgrades (UBS Neutral→Buy, HSBC Reduce→Hold) + +$17 / +$15 / +$10 PT raises across the universe. The two FY26 watch items: (1) does the cost program complete the remaining $1.2-2.2B savings on schedule; (2) does the Bumerangue appraisal program (starting end-2025) confirm the ~8B-barrel resource estimate. The Q1 FY26 earnings print this week is the proximate event for measuring continued production execution + Castrol sale closing + cost program progression + capital allocation guidance.